Sanjay Reddy, MD
Fox Chase Cancer Center · Bangalore Diabetes Centre
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sanjay Reddy, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:48 UTC. Open this list on ClinicalTrials.gov
- Early Ph1NCT05365893 · PHL Treatment in Pancreatic CancerFox Chase Cancer Center · active not recruiting · Pancreatic Ductal Adenocarcinoma · principal investigator
- Ph2NCT03179995 · Trial Using Octreotide to Enhance Liver Recovery After HepatectomyFox Chase Cancer Center · terminated · Major Liver Resection · principal investigator
- Ph2NCT00814372 · Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on MetforminGilead Sciences · terminated · Type 2 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Neoadjuvant Stroma Modification in Pancreatic CancerR21CA252535 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Igor Astsaturov, Efrat Dotan · fiscal years 2021 to 2022Named on NCT05365893
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.